⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15919240 | 0.93 | DPP7 (0.40) | — | |
| SCHEMBL5477147 | 0.81 | — | — | |
| SCHEMBL554749 | 0.81 | — | — | |
| SCHEMBL6956606 | 0.73 | — | — | |
| SCHEMBL4080897 | 0.72 | — | — | |
| SCHEMBL9023193 | 0.71 | CHRM2 (0.53) | — | |
| SCHEMBL9023196 | 0.71 | CHRM2 (0.53) | — | |
| SCHEMBL23942057 | 0.70 | — | — | |
| SCHEMBL4357889 | 0.70 | — | — | |
| SCHEMBL8298016 | 0.70 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115322129-A | Dicyano pyrrolidine derivative and preparation method and application thereof | 湖北科技学院 | 2022-11-11 | — | — | CN | claimed |
| CN-115322129-A | Dicyano pyrrolidine derivative and preparation method and application thereof | 湖北科技学院 | 2022-11-11 | — | — | CN | disclosed |
| CN-115322129-A | Dicyano pyrrolidine derivative and preparation method and application thereof | 湖北科技学院 | 2022-11-11 | — | — | CN | disclosed |
| CN-115322129-A | Dicyano pyrrolidine derivative and preparation method and application thereof | 湖北科技学院 | 2022-11-11 | — | — | CN | disclosed |
| US-20070238753-A1 | Pharmaceutical Compositions as Inhibitors of Dipeptidyl Peptidase-IV (DPP-IV) | MADAR DAVID J | 2007-10-11 | — | — | US | disclosed |
| US-7238724-B2 | Antidiabetic agents; hyperlipemic agents; obestity; immunomoderator; atherosclerosis | ABBOTT LABORATORIES (US) | 2007-07-03 | — | — | US | disclosed |
| US-20050215784-A1 | Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV) | ABBVIE INC. | 2005-09-29 | — | — | US | disclosed |